Recurrent or Progressive Malignant Glioma
1 clinical trials · Condition
◉ Watch Recurrent or Progressive Malignant Glioma
| Record | Firm | Date |
|---|---|---|
| A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma (NCT00539344) | Angiochem Inc | 2007-10-01 |
Track Recurrent or Progressive Malignant Glioma automatically
Every clearance here is in the API, with alerts when new ones post.